Europe Peripheral Intravenous Catheters Market

Europe Peripheral Intravenous Catheters Market Size

The europe peripheral intravenous catheters market was valued at USD 1.47 billion in 2025, is expected to have a 5.6% CAGR from 2026 to 2034, and be worth USD 2.40 billion by 2034 from USD 1.55 billion in 2026.

Peripheral Intravenous Catheters refer to the short-term vascular access devices inserted into superficial veins, typically in the forearm or hand, to administer fluids, medication,s, blood products, or contrast agents during acute or ambulatory care. These catheters, ranging from 14 to 24 gauge, are essential in emergency departments, surgical units, oncology wards, and home healthcare settings. Unlike central lines, peripheral intravenous catheters are designed for short-duration use, usually up to 72 to 96 hours, and are prioritized for their ease of insertion and lower complication profile when properly managed.

As of 2025, their clinical indispensability is emphasized by rising procedural volumes and evolving patient care models across the region. According to sources, millions of surgical procedures were performed in EU hospitals, a portion requiring peripheral venous access. Furthermore, as per research, as of January 1, 2025, the EU population was approximately 449.3 million, with 21.6% (about 97 million people) aged 65 or older and driving demand for chronic disease management that often involves repeated intravenous therapy. These structural healthcare utilization patterns affirm the device’s foundational role in modern clinical practice.

MARKET DRIVERS

Escalating Surgical and Emergency Care Volumes Across EU Hospitals

The sustained increase in surgical and acute care interventions fuels the growth of the Europe peripheral intravenous catheters market. According to studies, EU member states performed millions of inpatient and day case surgeries in 2025, driven by aging demographics and expanded access to elective procedures. Each of these interventions requires at least one peripheral IV line for anesthesia fluid resuscitation and postoperative medication delivery. In Germany, it recorded millions of hospital surgeries in 2025, with many involving peripheral venous access as standard protocol. Similarly, emergency departments across France handled a large number of visits in 2025, with intravenous access established in many adult cases. This procedural ubiquity, supported by clinical guidelines from bodies like the European Resuscitation Council, ensures consistent and non-discretionary device utilization across all levels of acute care.

Expansion of Home Healthcare and Ambulatory Infusion Services

The shift from inpatient to community-based care is further boosting the expansion of the Europe peripheral intravenous catheters market. As per research, many EU countries expanded home healthcare reimbursement frameworks to include long-term intravenous antibiotic, antifungal, and hydration therapies. In the Netherlands, a considerable number of patients received outpatient parenteral therapy at home. These treatments rely on durable peripheral catheters that remain functional for 3 to 5 days with proper maintenance. This decentralization of care—accelerated by workforce shortages and patient preference—transforms peripheral IVs from transient hospital tools into extended use devices in community settings, creating new demand vectors for fosafety-engineered and infection-resistant variants.

MARKET RESTRAINTS

High Incidence of Catheter-Related Complications Leading to Clinical Hesitancy

Complication rates are constraining optimal utilization, which hampers the growth of the Europe peripheral intravenous catheters market. As per studies, peripheral intravenous procedures in European healthcare settings frequently encounter complications such as phlebitis, infiltration, and occlusion, indicating ongoing challenges in vascular access management. More critically, bloodstream infections associated with peripheral catheters continue to represent a notable risk in clinical environments, which emphasizes the importance of enhanced aseptic protocols and monitoring systems. These adverse outcomes foster clinical reluctance to rely solely on peripheral access for extended therapies, which prompts earlier escalation to midline or central catheters in high-risk patients. The current high rate of complications necessitates clinical caution, which, in turn, is suppressing catheter use per patient and shifting the market toward alternative access methods.

Stringent Regulatory Classification and Conformity Assessment Requirements

The European Union’s Medical Device Regulation imposes rigorous conformity pathways that delay product innovation and market entry and hinder the expansion of the Europe peripheral intravenous catheters market. As per the European Commission, peripheral IV catheters are classified as Class IIa medical devices requiring notified body review of clinical evaluation reports and post-market surveillance plans. The regulatory burden disproportionately affects small and medium enterprises. Such barriers stifle the introduction of next-generation safety features like antimicrobial coatings or integrated ultrasound guidance, which slows the market’s ability to address clinical challenges through innovation.

MARKET OPPORTUNITIES

Integration of Smart Catheters with Digital Monitoring Systems

The emergence of connected peripheral IV catheters is setting up new opportunities for the growth of the Europe peripheral intravenous catheters market. These devices embed microsensors to detect infiltration, occlusion,n or dislodgement in real time and transmit alerts to nursing stations via hospital Wi-Fi networks. A scalable technical foundation is in place, given that numerous EU hospitals now use digital infrastructure in line with the 2030 Digital Decade targets. The shift in healthcare toward predictive analytics and early intervention is driving the evolution of smart peripheral catheters from a niche innovation to a standard treatment in high-acuity settings.

Adoption of Antimicrobial and Antithrombotic Coated Catheters

Advanced surface modifications offer a compelling pathway to mitigate the leading causes of peripheral IV failure, thus creating potential prospects for the expansion of the Europe peripheral intravenous catheter market. Catheters impregnated with chlorhexidine, silver sulfadiazine, or heparin have demonstrated significant reductions in infection and thrombosis rates in European clinical settings. As per studies, patients using usinantithrombotic-coated catheters experienced a lower incidence of occlusion compared to standard polyurethane lines. These outcomes align with the EU’s One Health Action Plan against antimicrobial resistance, which encourages medical devices that reduce unnecessary antibiotic use. The clinical benefits of premium coated catheters are now supported by economic evidence as reimbursement structures adapt to value-based care.

MARKET CHALLENGES

Persistent Shortage of Skilled Clinical Staff for Proper Insertion and Maintenance

The chronic deficit of trained personnel capable of consistent aseptic insertion and ongoing care slows down the growth of the Europe peripheral intravenous catheters market. According to research, the EU faced a shortfall of nurses, with Southern and Eastern member states experiencing vacancy rates exceeding a notable percentage. This staffing crisis leads to rushed placements and inadequate monitoring. Advanced catheters cannot fulfill their potential without sufficient staff training and expertise. This shortage inevitably compromises patient safety and diminishes faith in peripheral access as a reliable treatment.

Price Sensitivity and Procurement Pressures in Public Healthcare Systems

Intense cost containment in the region’s predominantly public healthcare systems suppresses adoption of higher value peripheral IV technologies and constrains the expansion of the Europe peripheral intravenous catheters market. As per sources, many catheter purchases in EU hospitals occur through centralized tenders that prioritize the lowest price over clinical performance. The price-driven environment disincentivizes innovation and locks systems into legacy products despite evidence of long-term cost savings from reduced complications. The market will favor mass-produced devices that do not solve critical clinical problems until value-based procurement models become more widely adopted.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

The integrated/closed PIVC segment led the Europe peripheral intravenous catheters market and captured a 58.7% share in 2025. The prominence of the integrated/closed PIVC segment is attributed to its engineered ability to minimize bloodstream infection risks by eliminating open connections during administration. According to sources, catheter-related bloodstream infections accounted for a portion of all healthcare-associated infections in EU acute care hospitals, with open systems contributing disproportionately. Integrated catheters feature pre-attached extension tubing and needle-free valves that maintain a continuous closed circuit, reducing microbial ingress. This clinical advantage aligns with the EU’s Healthcare-Associated Infection Reduction Target. Consequently, national protocols recommend or require closed systems for all high-risk patients, cementing their status as the standard of care. European regulatory and purchasing frameworks increasingly favor integrated designs as part of broader patient safety initiatives. Integrated PIVCs inherently comply by eliminating the need for secondary needle insertions during setup. These policy shifts transform clinical preference into institutional mandate, ensuring sustained volume uptake across high utilization departments and reinforcing the segment’s market dominance.

The Short PIVC (Ported Peripheral Intravenous Catheter) segment is predicted to witness the highest CAGR of 9.8% from 2025 to 2033. The growth of ported short PIVCs is driven by their cost-effectiveness and simplicity in settings with limited infrastructure or staffing. In Eastern and Southern Europe, where healthcare budgets remain tight, these basic catheters offer a functional solution for short-term infusions without the premium cost of integrated systems. According to research, a share of primary hospitals in Romania, Bulgaria, and Greece rely exclusively on ported catheters due to procurement constraints. Apart from these, in rural clinics, ported PIVCs are preferred for their compatibility with manual syringe bolus administration, a common practice where infusion pumps are unavailable. Ported short catheters are uniquely suited for neonatal and pediatric care; a minimal device footprint is critical. Unlike integrated systems with extension tubing, short ported catheters reduce limb immobilization and dislodgement risk in small patients. This clinical niche, combined with Europe’s annual births, creates a stable and growing demand segment that prioritizes anatomical compatibility over advanced safety features, which fuels specialized innovation and adoption.

By Type Insights

The integrated/closed catheters segment remained the top-performing segment in the Europe peripheral intravenous catheters market by accounting for 61.3% share in 2025. Alignment with EU patient safety and infection control mandates, and compatibility with modern infusion and electronic health record systems have majorly contributed to the growth of the integrated/closed catheters segment in the regional market. Integrated/closed catheters are the cornerstone of Europe’s strategy to reduce preventable harm in acute care. According to studies, hospitals using integrated PIVCs as standard reported a lower rate of phlebitis and a reduction in catheter occlusion compared to facilities using open systems. This regulatory endorsement, coupled with real-world evidence of clinical benefit, has made integrated catheters the default choice in high acuity environments across Germany, France, and the Nordic countries, where quality metrics directly influence hospital funding. The design of integrated catheters facilitates seamless integration with automated drug delivery and digital documentation workflows. Their standardized Luer lock connectors and pre-attached tubing align with smart infusion pumps that require closed circuits to enable dose error reduction software. This synergy with Europe’s broader digital health transformation ensures that closed systems are not only clinically superior but also operationally indispensable in modernized care settings.

The peripheral insertion catheters segment is estimated to register the fastest CAGR of 8.5% from 2025 to 2033, owing to their adaptability in non-hospital environments where simplicity and patient mobility are paramount. Unlike bulkier integrated systems, these catheters allow direct medication bolus or connection to lightweight portable pumps. As per sources, outpatient parenteral antimicrobial therapy programs expanded to cover millions of patients in 2025. In Switzerland, a share of home infusion nurses prefer peripheral insertion catheters for their ease of dressing and reduced tubing entanglement during daily activities, as per studies. This preference is reinforced by patient feedback. This user-centered advantage ensures robust demand in decentralized care models. Peripheral insertion catheters remain the device of choice for short-duration, low-complexity interventions such as preoperative hydration or single-dose antibiotic administration. Their lower unit cost, typically less than integrated variants, makes them economically rational for high turnover settings. This strategic deployment in appropriate use cases sustains volume growth without compromising safety.

By End User Insights

In 2025, the hospitals segment dominated the Europe peripheral intravenous catheters market by occupying a substantial share 2025. The dominance of the hospitals segment is because of their role as the primary site for acute interventions requiring immediate vascular access. According to research, EU hospitals performed millions of inpatient admissions in 2025, with a portion involving a peripheral IV line for fluid resuscitation, medication delivery, or blood sampling. Emergency departments alone accounted for millions of visits, as per studies, with IV access established in a share of adult cases within the first few minutes of arrival. National clinical guidelines reinforce this ubiquity. Furthermore, surgical units require dual IV access for anesthesia and intraoperative support. This procedural density, combined with regulatory mandates, ensures hospitals remain the largest and most consistent end-user segment. Hospital dominance is further entrenched by centralized purchasing systems that standardize catheter types across entire networks. This institutional buying power not only drives volume but also accelerates the adoption of advanced features like antimicrobial coatings or RFID tracking. The growing trend of hospitals prioritizing quality indicators like infection rates and nurse satisfaction in their device selection empowers them to maintain their position as the main driver of the peripheral IV catheter.

The Home Use and Others segment is anticipated to witness the fastest CAGR of 12.4% over the forecast period, owing to deliberate policy efforts to decongest hospitals and improve patient experience. These treatments, ranging from antibiotics to immunoglobulin replacement, rely on durable peripheral catheters that remain functional for 3 to 5 days. This systemic redirection of care creates a new and expanding channel for peripheral catheter consumption outside traditional institutions. Home use is further accelerated by programs that train patients or caregivers to manage simple IV regimens. This model not only improves the quality of life but also reduces system costs. The high growth of home-based catheter use is expected to continue, driven by digital health tools that allow for remote monitoring of catheter sites.

COUNTRY LEVEL ANALYSIS

Germany Peripheral Intravenous Catheters Market Analysis

Germany was the largest region in the Europe peripheral intravenous catheters market by accounting for 23.1% in 2025. Its high hospital density, advanced healthcare infrastructure, and stringent patient safety regulations are driving the domination of Germany. The country performs millions of surgical procedures annually, according to studies, each requiring a peripheral IV line. Germany’s Hospital Future Act allocated funds to modernize clinical workflows, including the adoption of safety-engineered catheters. Besides, Germany hosts Europe’s largest nursing workforce with registered professionals ensuring high procedural volume and adherence to best practices. These structural and regulatory factors support Germany’s position as the region’s leading market for both standard and advanced peripheral catheters.

France Peripheral Intravenous Catheters Market Analysis

France is the next prominent region in the Europe peripheral intravenous catheters market and captured 17.8% share in 2025. The growth of France is fuelled by centralized healthcare procurement and national clinical guidelines that standardize vascular access protocols. As per studies, many public hospitals now exclusively use integrated/closed PIVCs following the update to the National Patient Safety Program. France also leads in emergency care volume with annual ED visits requiring rapid IV access. The Groupement Hospitalier de Territoire procurement model ensures uniform device selection across regions, reducing fragmentation and accelerating innovation uptake. Furthermore, Anc’s strong home care expansion creates dual demand in institutional and community settings. This combination of top-down standardization and bottom-up service diversification sustains France’s high intensity catheter consumption.

United Kingdom Peripheral Intravenous Catheters Market Analysis

The United Kingdom is also a key region in the Europe peripheral intravenous catheters market due to evidence-based procurement and a strong focus on reducing healthcare-associated infections. According to sources, millions of peripheral IV starts were documented, with a portion using closed systems. The UK also pioneers nurse-led vascular access teams that improve first attempt success rates and reduce complications, key performance indicators tied to hospital funding. Post-Brexit regulatory autonomy has enabled faster adoption of novel catheter designs through the Medicines and Healthcare products Regulatory Agency’s innovation pathway. These systemic enablers ensure the UK remains a high-value and high-compliance market for advanced peripheral IV technologies.

Italy Peripheral Intravenous Catheters Market Analysis

Italy is moving ahead steadily in the Europe peripheral intravenous catheters market, with regional variation and growing alignment with EU safety standards. Integrated catheters are the standard in Northern university hospitals, while Southern regions, facing budget constraints, continue to use basic ported designs. However, the National Plan for Infection Prevention allocated funds to upgrade vascular access devices in public hospitals, accelerating convergence. Italy also has Europe’ssecond-largestt home care sector, supporting a large number of patients on outpatient IV therapy. This dual dynamic of institutional modernization and community care expansion positions Italy as a high-potential growth market.

Spain Peripheral Intravenous Catheters Market Analysis

Spain is likely to grow in the Europe peripheral intravenous catheters market from 2025 to 2033, owing to its extensive network of ambulatory surgery centers and emergency departments. Spain’s decentralized healthcare system allows autonomous communities to set procurement policies, leading to variation but also innovation. Catalonia and Andalusia have implemented mandatory closed system use in all public hospitals since 2023. Furthermore, Spain leads in home infusion growth. The combination of high procedural volume in both hospital and outpatient settings, along with progressive regional policies, ensures Spain’s continued prominence in the European peripheral IV catheter landscape.

COMPETITIVE LANDSCAPE

The Europe Peripheral Intravenous Catheters Market features intense competition among global medtech leaders and specialized European manufacturers. Companies such as Becton Dickinson, B. Braun,n and Smiths Medical dominate through extensive distribution networks,r egulatory expertise, and clinical credibility, while regional players like Vygon and B. Braun's subsidiaries compete on localized support and cost efficiency. Differentiation hinges on safety features, infection prevention capabilities,,s and compatibility with digital health workflows. The market is highly regulated with stringent conformity requirements under the EU Medical Device Regulation, which creates high entry barriers for new entrants. Price pressure from centralized public procurement systems in countries like France and Spain further intensifies rivalry, pushing companies to demonstrate long-term value through reduced complication rates and nursing time savings. As hospitals prioritize quality metrics tied to funding innovation in catheter design and training support has become a critical competitive lever.

KEY MARKET PLAYERS

Key players in the europe PVIC market profiled in this report are

• Smith Medical,
• Terumo Corporation
• C. R. Bard, Inc.
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Tangent Medical
• Vygon Group.

TOP LEADING PLAYERS IN THE MARKET

• Becton Dickinson and Company maintains a strong presence in the Europe Peripheral Intravenous Catheters Market through its comprehensive portfolio of safety-engineered vascular access devices, including the BD Nexiva and BD Insyte families. The company aligns its product design with EU patient safety directives and infection control guidelines. This innovation supports its global mission to reduce catheter-related complications and reinforces its dominance in acute care settings across North America, a Euro, and Asia through standardized yet locally adapted solutions.
• Braun SE is a key European manufacturer deeply embedded in regional healthcare systems, with its Introcan Safety and Certofix product lines widely usedin Germana,n French, and Italian hospitals. The company emphasizes compliance with the European Union Medical Device Regulation and invests in local clinical education programs to promote best practices in venous access. This advancement strengthens its contribution to global infection prevention efforts and enhances its reputation as a science-driven European innovator in vascular access.
• Smiths Medical plays a significant role in the Europe Peripheral Intravenous Catheters Market through its Jelco and Portex branded catheters, known for reliability in emergency and pediatric settings. The company leverages ICU Medical’s global R and D infrastructure to adapt products for European clinical workflows and regulatory requirements. This field-based educational strategy not only improves clinical outcomes but also extends the company’s influence in both European and international markets through evidence-based implementation.

TOP STRATEGIES USED BY THE KEY MARKET PARTICIPANTS

Key players in the Europe Peripheral Intravenous Catheters Market prioritize compliance with the European Union Medical Device Regulation by investing in robust clinical evaluation and post-market surveillance systems. They develop closed system and safety-engineered catheters that align with national infection control mandates and patient safety targets. Companies engage in extensive clinical education programs for nurses and physicians to ensure proper insertion and maintenance practices. Strategic collaborations with academic hospitals and research institutes drive innovation in antimicrobial coatings and catheter stabilization. Apart from these, they tailor product portfolios to meet the distinct needs of hospital emergency home care and ambulatory settings across diverse EU member states.

MARKET SEGMENTATION

The European peripheral intravenous catheters market has been segmented and sub-segmented into the following categories.

By Product

• Short PIVC (Ported Peripheral Intravenous Catheter
• Non-ported Peripheral Intravenous Catheter)
• Integrated/Closed PIVC

By Type

• Integrated/Closed catheters
• Peripheral insertion catheters

By End User

• Hospitals
• Clinics Ambulatory Surgery Centers (ASCs)
• Home Use and Others

By Technology

• Conventional Peripheral Intravenous Catheter
• Safety Peripheral Intravenous Catheter

By Country

• United Kingdom
• France
• Spain,
• Germany
• Italy Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Rest of Europe